绝经年龄与全因及病因特异性痴呆:英国生物银行队列的前瞻性分析
基于英国生物银行160080名女性的前瞻性队列显示,与绝经年龄46-50岁相比,自然绝经≤40岁和41-45岁与全因痴呆风险升高相关,自然绝经>55岁与风险降低相关;手术绝经与痴呆风险呈U型关系,<40岁和>55岁手术绝经均与风险升高相关。
要点
- 自然绝经≤40岁和41-45岁较46-50岁与全因痴呆风险升高相关。
- 自然绝经>55岁较46-50岁与全因痴呆风险降低相关。
- 手术绝经<40岁和>55岁均与全因痴呆风险升高相关,呈U型关系。
核心结论
- 与绝经年龄46-50岁相比,自然绝经≤40岁和41-45岁与全因痴呆风险升高相关,自然绝经>55岁与风险降低相关。
- 手术绝经与痴呆风险呈U型关系,<40岁和>55岁手术绝经均与全因痴呆风险升高相关。
研究设计与样本
- 基于英国生物银行的前瞻性人群队列研究,纳入160080名女性。
- 纳入基线无痴呆且关键暴露变量和协变量无缺失数据的女性。
- 采用Cox比例风险模型估计绝经年龄分类与 incident 全因痴呆、阿尔茨海默病(AD)和血管性痴呆(VD)关联的HR和95%CI。
- 采用限制性立方样条模拟连续自然绝经、手术绝经年龄与痴呆风险的非线性关系。
- 分析基线曾使用绝经激素治疗(MHT)、收入水平、休闲活动与绝经年龄对痴呆风险的交互效应。
主要发现
- 与绝经年龄46-50岁相比,自然绝经<40岁全因痴呆HR 1.36(95%CI 1.01-1.83),41-45岁HR 1.19(95%CI 1.03-1.39)。
- 与绝经年龄46-50岁相比,自然绝经>55岁全因痴呆HR 0.83(95%CI 0.71-0.98)。
- 与自然绝经相比,手术绝经与痴呆风险升高10%相关(HR 1.10,95%CI 0.98-1.24)。
- 手术绝经<40岁全因痴呆HR 1.94(95%CI 1.38-2.73),>55岁HR 1.65(95%CI 1.21-2.24)。
- 基线未使用MHT的早期自然绝经女性AD风险升高;各绝经年龄分类中,较高收入水平或较多休闲活动与较低痴呆风险相关。
临床怎么用
- 作者认为,自然绝经或较早年龄手术绝经的女性需要密切监测和参与预防性健康措施以延迟痴呆发展。
局限性
- 绝经年龄基于女性自我报告,可能引起回忆偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Are there associations between natural or surgical menopause and incident dementia by age at menopause? SUMMARY ANSWER: Compared to age at menopause of 46-50 years, earlier natural menopause (≤40 and 41-45 years) was related to higher risk of all-cause dementia, while a U-shape relationship was observed between age at surgical menopause and risk of dementia. WHAT IS KNOWN ALREADY: Menopause marks the end of female reproductive period. Age at menopause reflects the length of exposure to endogenous estrogen. Evidence on the association between age at natural, surgical menopause, and risk of dementia has been inconsistent. STUDY DESIGN, SIZE, DURATION: A population-based cohort study involving 160 080 women who participated in the UK Biobank study. PARTICIPANTS/MATERIALS, SETTING, METHODS: Women with no dementia at baseline, and had no missing data on key exposure variables and covariates were included. Cox proportional hazards models were used to estimate hazard ratios (HRs) and 95% CIs on the association of categorical menopause age with incident all-cause dementia, Alzheimer's disease (AD) and vascular dementia (VD). Restricted cubic splines were used to model the non-linear relationship between continuous age at natural, surgical menopause, and risk of dementia. In addition, we analyzed the interaction effect of ever-used menopausal hormone therapy (MHT) at baseline, income level, leisure activities, and age at menopause on risk of dementia. MAIN RESULTS AND THE ROLE OF CHANCE: Compared to women with age at menopause of 46-50 years, women with earlier natural menopause younger than 40 years (1.36, 1.01-1.83) and 41-45 years (1.19, 1.03-1.39) had a higher risk of all-cause dementia, while late natural menopause >55 years was linked to lower risk of dementia (0.83, 0.71-0.98). Compared to natural menopause, surgical menopause was associated with 10% higher risk of dementia (1.10, 0.98-1.24). A U-shape relationship was observed between surgical menopause and risk of dementia. Women with surgical menopause before age 40 years (1.94, 1.38-2.73) and after age 55 years (1.65, 1.21-2.24) were both linked to increased risk of all-cause dementia. Women with early natural menopause without ever taking MHT at baseline had an increased risk of AD. Also, in each categorized age at the menopause level, higher income level or higher number of leisure activities was linked to a lowers risk of dementia. LIMITATIONS, REASONS FOR CAUTION: Menopausal age was based on women's self-report, which might cause recall bias. WIDER IMPLICATION OF THE FINDINGS: Women who experienced natural menopause or had surgical menopause at an earlier age need close monitoring and engagement for preventive health measures to delay the development of dementia. STUDY FUNDING/COMPETING INTERESTS: This work was supported by the Start-up Foundation for Scientific Research in Shandong University (202099000066), Science Fund Program for Excellent Young Scholars of Shandong Provence (Overseas) (2022HWYQ-030), and the National Natural Science Foundation of China (82273702). There are no competing interests. TRIAL REGISTRATION NUMBER: N/A.
引用
- Hao W, Fu C, Dong C, et al. Age at menopause and all-cause and cause-specific dementia: a prospective analysis of the UK Biobank cohort. Hum Reprod. 2023. PMID: 37344154. doi:10.1093/humrep/dead130
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。